I thought the NIH had fully funded the ARDS trial, so much positive things going on at the moment, pretty hard to keep up. SI and the team must be a machines to stay on top with the blistering pace at the moment, no wonder the big pharma want in as I believe we're close to the pointy end of the trip or maybe the start for some.
Can't think of what's on the back burner at the moment, may need to take a breath or escape to the bush over the next couple of months while thinking of the effect on the SP let alone the benefit these treatments bring to people as they get rolled out.
Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-132
-
- There are more pages in this discussion • 680 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71720 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 10463 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |